TT Comparing efficacy between remdesevir, ritonavir/lopinavir, hidroxicloroquina e interferón beta.
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$240,840Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
PendingResearch Location
SpainLead Research Institution
Instituto de Investigación Sanitaria del Hospital Clínico de MadridResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Clinical trial (unspecified trial phase)
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
TT Comparing efficacy between remdesevir, ritonavir/lopinavir, hidroxicloroquina e interferón beta.